Cypress Pharmaceuticals Private Limited
About Cypress Pharmaceuticals Private Limited
Data last updated:
Cypress Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 07 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC292146. Its GSTIN is 10AAGCC8721M1ZO (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.38 Cr and a paid-up capital of ₹1.3 Cr. It is led by directors Lav Kumar and Rakesh Kumar Ranjan.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Flat No. F/604 Elite Building Kalyan Shil Road Nilje, Mumbai, Maharashtra, India – 421203.
As per the financials filed for FY 2020, the company reported a revenue of ₹80.44 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹79.41 Lakh (net margin -98.7%) and EBITDA of -₹77.48 Lakh (EBITDA margin -96.3%).
Court records list 4 cases involving the company, including 4 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cypress Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. F/604 Elite Building Kalyan Shil Road Nilje, Mumbai, Maharashtra, India – 421203
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Cypress Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cypress Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cypress Pharmaceuticals Private Limited, buy the company report.
Financials of Cypress Pharmaceuticals Private Limited
FY 2020 filings availableCypress Pharmaceuticals Private Limited reported revenue of ₹80.44 Lakh (down 84% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 84% in the latest year. EBITDA fell 20% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹80.44 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹77.48 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹79.41 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -96.3% | |||
| Net Profit Margin | -98.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Cypress Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cypress Pharmaceuticals Private Limited
Cypress Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lav Kumar | Director | 20 Jul 2020 | 6 Years 3 Months | Current |
| Rakesh Kumar Ranjan Also directs: Winnet Nidhi Limited, Gayatriindia Bhavishya Nidhi Limited, Winnet Mutual Nidhi Limited and 3 more | Director | 26 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Cypress Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Belgrand Pharmaceuticals Private Limited | ₹80.59 Lakh (FY 2024) | 21.0% | Hyderabad, Telangana, India | |||
| Cypress Pharmaceuticals Private Limitedthis company | ₹80.44 Lakh (FY 2020) | -₹79.41 Lakh | -98.7% | -84.0% | Mumbai, Maharashtra, India | |
| Medyur Pharmaceuticals Limited | ₹80.41 Lakh (FY 2025) | 68.0% | New Delhi, Delhi, India | |||
| Usbi Ventures Private Limited | ₹80.37 Lakh (FY 2025) | 194.0% | Ernakulam, Kerala, India | |||
| Loyol Pharmaceuticals Private Limited | ₹80.32 Lakh (FY 2021) | Balasore, Odisha, India |
To see the full peer comparison of Cypress Pharmaceuticals Private Limited, buy the company report.
Auditor
Cypress Pharmaceuticals Private Limited is audited by PAWAN TIWARY & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAWAN TIWARY & ASSOCIATES | FY 2020 | 019239C |
Shareholding
The shareholding of Cypress Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Cypress Pharmaceuticals Private Limited, buy the company report.
Legal cases
Cypress Pharmaceuticals Private Limited has 4 court cases on record: 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Civil suit | Filed against the company by Om Logistics Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Theon Pharmaceuticals Ltd | Disposed |
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by M/S Ravian Life Science Pvt. Authority - Uday Narayan Rai | Disposed |
To see the full case history of Cypress Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cypress Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cypress Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCC8721M1ZO | Bihar | Active | 25 Feb 2020 |
To see the full GST registrations and return filing status of Cypress Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cypress Pharmaceuticals Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Lav Kumar ceased to be Director on 05 Sep 2022.
Frequently asked questions
Cypress Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 07 March 2017 (9+ years old) and is registered under CIN U74999MH2017PTC292146.
Cypress Pharmaceuticals has 2 current directors:
- Lav Kumar - Director
- Rakesh Kumar Ranjan - Director
The latest financial statements of Cypress Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Cypress Pharmaceuticals is 10AAGCC8721M1ZO, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Cypress Pharmaceuticals is U74999MH2017PTC292146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cypress Pharmaceuticals has 4 court cases on record: 4 filed against it.
Cypress Pharmaceuticals was incorporated on 07 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cypress Pharmaceuticals by revenue are Belgrand Pharmaceuticals Private Limited, Medyur Pharmaceuticals Limited, Usbi Ventures Private Limited, Loyol Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Lav Kumar ceased to be Director on 05 Sep 2022. Lav Kumar was appointed as Director on 20 Jul 2020. Onkar Nath Prasad ceased to be Director on 20 Jul 2020. Cypress Pharmaceuticals has 7 board changes on record in total.
The registered office of Cypress Pharmaceuticals is at Flat No. F604 Elite Building Kalyan Shil Road Nilje, Mumbai, Maharashtra, India – 421203.
Cypress Pharmaceuticals operates in the healthcare industry, in the ayurvedic products and services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
